Brief info
KI is Sweden’s foremost medical university and a global leader in biomedical research. It conducts 40% of Sweden’s academic medical research and offers extensive opportunities for translational studies, benefiting from proximity to Stockholm’s major hospitals. The Loré lab focuses on novel vaccine platforms and understanding the induction of potent and durable vaccine immunity. The group has vast experience performing large preclinical vaccine studies in non-human primates as well as clinical vaccine studies in collaboration with both academia and industry. In the EAVI project, the group will in-detail characterize and evaluate T cell responses over time in peripheral blood samples from individuals vaccinated with the live-attenuated licensed Chikungunya vaccine.